Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma
Our study on DAP3 can provide a reference for HCC diagnosis, treatment and prognosis assessment.
Authors
- Zhiqiang Yue
- Qi Ma (ORCID: https://orcid.org/0000-0001-9925-6492)
- Xiao Feng (ORCID: https://orcid.org/0000-0002-3282-5301)
- Lin Chen (ORCID: https://orcid.org/0000-0002-1108-4735)
- Peng Zhāng (ORCID: https://orcid.org/0000-0001-7956-2708)
- Liu-Xia Yuan
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3389/fimmu.2025.1528853
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00